Cost Effectiveness of Testing for Chlamydial Infections in Asymptomatic Women

Buhaug, Harald; Skjeldestad, Finn Egil; Backe, Bjørn; Dalen, Are

doi:10.1097/00005650-198908000-00007

Cited by 30 publications

(15 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Further details of each study are summarised in Appendix 4. Eleven papers evaluated selective opportunistic screening, 131,[185][186][187][188][189][190][191][192] including two cost studies. 144,193 These studies were based in settings such as general practice, family planning and antenatal clinics, and selected individuals based on specified criteria, including age.…”

Section: Studies Of Chlamydia Screening Interventionsmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Low

McCarthy²,

Macleod³

et al. 2007

Health Technol Assess

134

179

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) programme, now part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the costs, effectiveness and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as r...

show abstract

Section: Studies Of Chlamydia Screening Interventionsmentioning

confidence: 99%

“…In terms of analytical approach, 12 studies used no model, 34 studies used a static decision tree, two used Markov chain models, 190,206 one used an unspecified simulation model 189 and one used an undefined 'mathematical model'. 225 The most recent paper used a state-transition model.…”

Section: Other Characteristics Of Studiesmentioning

confidence: 99%

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Low

McCarthy²,

Macleod³

et al. 2007

Health Technol Assess

134

179

View full text Add to dashboard Cite

show abstract

“…Chlamydia is not cost-effective when tested in general population (Buhaug et al, 1989;Roberts et al, 2007;van Valkengoed et al, 2001) and that only when women aged 18 to 24 years old tested or prevalence of Chlamydia is over 3% (Postma et al, 2000) or 2% (Trachtenberg et al, 1988), cost-effectiveness exist for prevention of ectopic pregnancy. Hu et al, pointed out that annual screening for Chlamydia is indicated for women 15 to 29 years of age and selective targeting with semiannual screening of those women with a history of infection (Hu et al, 2004).…”

Section: Sectionmentioning

confidence: 99%

Ectopic Pregnancy and Assisted Reproductive Technologies: A Systematic Review

Velalopoulou¹,

Peschos²,

Ospan³

et al. 2011

Ectopic Pregnancy - Modern Diagnosis and Management

View full text Add to dashboard Cite

“…Such an approach can provide valuable insights, together with a useful conceptual framework for bringing together facts and values (Lilford and Royston 1998), but is limited in the amount of complexity it can handle, particularly dynamic complexity. These previous studies suered, therefore, from a variety of limitations, notably that they ignored the possibility of re-infection (and hence the necessity for re-screening) as well as the likely reduction in further transmission as a result of reducing the current number of infective individuals in the population (i.e., the population prevalence) (Trachtenberg et al 1988;GencË and MaÊ rdh 1996;Haddix et al 1995;Nuovo et al 1995;Buhaug et al 1989;Gove 1997). The experimental studies dealt with populations that were already regular attendees at health care settings and merely had to have screening administered.…”

Section: Chlamydia Screeningmentioning

confidence: 99%